Characterization of the NleF effector protein from attaching and effacing bacterial pathogens

FEMS Microbiology Letters

Volumn 281, Issue 1, 2008, Pages 98-107

  Echtenkamp, Frank ^a   Deng, Wanyin ^c   Wickham, Mark E ^b,c   Vazquez, Alejandra ^d   Puente, Jose L ^d   Thanabalasuriar, Ajitha ^e   Gruenheid, Samantha ^e   Finlay, B Brett ^c   Hardwidge, Philip R ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

^b PHILIPS RESEARCH LABORATORIES   (Germany)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Bacterial pathogenesis; EHEC; Gnotobiotic piglet; NleF; Type III secretion

Indexed keywords

BACTERIAL PROTEIN; PROTEIN NLEF; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELLULAR DISTRIBUTION; CITROBACTER RODENTIUM; CONTROLLED STUDY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI O157; FEMALE; GNOTOBIOTICS; HELA CELL; HEMORRHAGIC COLITIS; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TRANSPORT; SWINE;

BACTERIA (MICROORGANISMS); CITROBACTER RODENTIUM; ESCHERICHIA COLI; MUS;

EID: 40349090137     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2008.01088.x     Document Type: Article

References (28)

1. Campellone KG, Robbins D & Leong JM (2004) EspFU is a translocated EHEC effector that interacts with Tir and N‐WASP and promotes Nck‐independent actin assembly. Dev Cell 7: 217–228.
2. Charpentier X & Oswald E (2004) Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM‐1 beta‐lactamase as a new fluorescence‐based reporter. J Bacteriol 186: 5486–5495.
3. Dahan S, Wiles S, La Ragione RM et al. (2005) EspJ is a prophage‐carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics. Infect Immun 73: 679–686.
4. Datsenko KA & Wanner BL (2000) One‐step inactivation of chromosomal genes in Escherichia coli K‐12 using PCR products. Proc Natl Acad Sci USA 97: 6640–6645.
5. Deng W, Vallance BA, Li Y, Puente JL & Finlay BB (2003) Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol Microbiol 48: 95–115.
6. Deng W, Puente JL, Gruenheid S et al. (2004) Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci USA 101: 3597–3602.
7. Francis DH, Moxley RA & Andraos CY (1989) Edema disease‐like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7. Infect Immun 57: 1339–1342.
8. Garmendia J, Frankel G & Crepin VF (2005) Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect Immun 73: 2573–2585.
9. Gruenheid S, Sekirov I, Thomas NA et al. (2004) Identification and characterization of NleA, a non‐LEE‐encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 51: 1233–1249.
10. Hueck CJ (1998) Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 62: 379–433.
11. Kelly M, Hart E, Mundy R et al. (2006) Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect Immun 74: 2328–2337.
12. Kim J, Thanabalasuriar A, Chaworth‐Musters T et al. (2007) The bacterial virulence factor NleA binds and disrupts function of the mammalian COP II complex. Cell Host Microbe 2: 160–171.
13. Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, Young CR & Sotman S (1978) Escherichia coli strains that cause diarrhoea but do not produce heat‐labile or heat‐stable enterotoxins and are non‐invasive. Lancet 1: 1119–1122.
14. Marches O, Ledger TN, Boury M et al. (2003) Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol 50: 1553–1567.
15. Marches O, Wiles S, Dziva F et al. (2005) Characterization of two non‐locus of enterocyte effacement‐encoded type III‐translocated effectors, NleC and NleD, in attaching and effacing pathogens. Infect Immun 73: 8411–8417.
16. McDaniel TK, Jarvis KG, Donnenberg MS & Kaper JB (1995) A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci USA 92: 1664–1668.
17. McKee ML, Melton‐Celsa AR, Moxley RA, Francis DH & O'Brien AD (1995) Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp‐2 cells. Infect Immun 63: 3739–3744.
18. Naylor SW, Low JC, Besser TE et al. (2003) Lymphoid follicle‐dense mucosa at the terminal rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in the bovine host. Infect Immun 71: 1505–1512.
19. Ogura Y, Ooka T, Asadulghani JT et al. (2007) Extensive genomic diversity and selective conservation of virulence‐determinants in enterohemorrhagic Escherichia coli strains of O157 and non‐O157 serotypes. Genome Biol 8: R138.
20. Perna NT, Plunkett G III, Burland V et al. (2001) Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409: 529–533.
21. Schauer DB & Falkow S (1993) Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infect Immun 61: 2486–2492.
22. Thomas NA, Deng W, Baker N, Puente J & Finlay BB (2007) Hierarchical delivery of an essential host colonization factor in enteropathogenic Escherichia coli. J Biol Chem 282: 29634–29645.
23. Tobe T, Beatson SA, Taniguchi H et al. (2006) An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci USA 103: 14941–14946.
24. Tzipori S, Gunzer F, Donnenberg MS, De Montigny L, Kaper JB & Donohue‐Rolfe A (1995) The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection. Infect Immun 63: 3621–3627.
25. Vallance BA, Deng W, Jacobson K & Finlay BB (2003) Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun 71: 3443–3453.
26. Vlisidou I, Marches O, Dziva F, Mundy R, Frankel G & Stevens MP (2006) Identification and characterization of EspK, a type III secreted effector protein of enterohaemorrhagic Escherichia coli O157:H7. FEMS Microbiol Lett 263: 32–40.
27. Wickham ME, Lupp C, Vazquez A et al. (2007) Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE. Microbes Infect 9: 400–407.
28. Zhang Y, Laing C, Steele M et al. (2007) Genome evolution in major Escherichia coli O157:H7 lineages. BMC Genomics 8: 121.